- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bio-Thera Solutions Ltd (688177)
Bio-Thera Solutions Ltd stock price live, this page displays SS 688177 stock exchange data. View the 688177 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bio-Thera Solutions Ltd real time stock price chart below.
What Is the Bio-Thera Solutions Ltd Stock Price Today?
The Bio-Thera Solutions Ltd stock price today is 30.93.
What Is the Stock Symbol for Bio-Thera Solutions Ltd?
The stock symbol for Bio-Thera Solutions Ltd is ""688177.""
What Stock Exchange Does Bio-Thera Solutions Ltd Trade On?
Bio-Thera Solutions Ltd is listed and trades on the Shanghai stock exchange.
Is Bio-Thera Solutions Ltd a Good Stock to Buy?
Determining whether Bio-Thera Solutions Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688177 quote. (ISIN: CNE100003R98)
What Is the Bio-Thera Solutions Ltd Stock Price Today?
The Bio-Thera Solutions Ltd stock price today is 30.93.
What Is the Stock Symbol for Bio-Thera Solutions Ltd?
The stock symbol for Bio-Thera Solutions Ltd is ""688177.""
What Stock Exchange Does Bio-Thera Solutions Ltd Trade On?
Bio-Thera Solutions Ltd is listed and trades on the Shanghai stock exchange.
Is Bio-Thera Solutions Ltd a Good Stock to Buy?
Determining whether Bio-Thera Solutions Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688177 quote. (ISIN: CNE100003R98)
Shanghai
Currency in CNY
30.93
+0.16(+0.52%)
Closed·
Fair Value
An estimate of a Bio-Thera Solutions's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.65
31.00
52 wk Range
17.70
36.32
688177 Scorecard
Full Analysis
Net income is expected to grow this year
688177 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Bio-Thera Solutions's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.6531.00
52 wk Range
17.7036.32
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688177 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Bio-Thera Solutions's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
36.60
Upside
+18.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Bio-Thera Solutions Ltd Company Profile
Bio-Thera Solutions, Ltd., a biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally. The company offers QLETLI for treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn’s disease, and uveitis; POBEVCY to treat patients with metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent, recurrent, and metastatic cervical cancer; and BAT1806 for the treatment of rheumatoid arthritis, systemicjuvenile idiopathic arthritis, and cytokine release syndrome. It also develops BAT2206, a biosimilar drug candidate used to treat psoriasis, Crohn’s disease, and ulcerative colitis; BAT2306 to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis; and BAT4406F, BAT6026, BAT2606, and BAT2506 for treatment of various autoimmune diseases. In addition, the company develops BAT4306F, BAT1308, BAT1006, BAT4706, BAT6026, BAT6005, BAT6021, BAT7104, BAT8006, BAT8009, BAT8010, BAT8008, and BAT8007 for treatment of oncology; BAT2094 and BAT6024 to treat cardiovascular diseases; BAT5906 that is in Phase III clinical trial for the treatment for wet age-related macular degeneration (wAMD) and Phase II clinical trial for the treatment for diabetic macular edema (DME); and BAT2022 to treat respiratory infectious diseases. The company has a biosimilars alliance with STADA Arzneimittel AG to cover tocilizumab, an immunosuppressant monoclonal antibody indicated for certain inflammatory conditions. Bio-Thera Solutions, Ltd. was founded in 2003 and is headquartered in Guangzhou, China.
Compare 688177 to Peers and Sector
Metrics to compare | 688177 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688177PeersSector | |
|---|---|---|---|---|
P/E Ratio | −32.0x | −2.3x | −0.6x | |
PEG Ratio | 5.90 | 0.03 | 0.00 | |
Price/Book | 21.9x | 2.7x | 2.6x | |
Price / LTM Sales | 16.3x | 13.6x | 3.3x | |
Upside (Analyst Target) | 18.9% | 53.3% | 38.7% | |
Fair Value Upside | Unlock | −6.3% | 5.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 36.60
(+18.33% Upside)
Earnings
Latest Release
Aug 20, 2025
EPS / Forecast
-0.07 / --
Revenue / Forecast
235.33M / --
FAQ
What Stock Exchange Does Bio-Thera Solutions Trade On?
Bio-Thera Solutions is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for Bio-Thera Solutions?
The stock symbol for Bio-Thera Solutions is "688177."
What Is the Bio-Thera Solutions Market Cap?
As of today, Bio-Thera Solutions market cap is 13.78B.
What Is Bio-Thera Solutions's Earnings Per Share (TTM)?
The Bio-Thera Solutions EPS (TTM) is -0.96.
When Is the Next Bio-Thera Solutions Earnings Date?
Bio-Thera Solutions will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is 688177 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Bio-Thera Solutions Stock Split?
Bio-Thera Solutions has split 0 times.
How Many Employees Does Bio-Thera Solutions Have?
Bio-Thera Solutions has 1266 employees.
What is the current trading status of Bio-Thera Solutions (688177)?
As of 28 Aug 2025, Bio-Thera Solutions (688177) is trading at a price of 30.93, with a previous close of 30.77. The stock has fluctuated within a day range of 29.65 to 31.00, while its 52-week range spans from 17.70 to 36.32.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.